Teva agrees to pay $126 million to US hospitals over opioids

Teva Pharmaceutical Industries Ltd (TEVA.TA) has agreed to pay up to $126 million to U.S. hospitals over 18 years to settle claims that its marketing of opioid drugs raised the hospitals' operating costs.